173 related articles for article (PubMed ID: 19100922)
21. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
22. Antitumor effects of an imidazoquinoline in renal cell carcinoma.
Schwartz MJ; Liu H; Hwang DH; Kawamoto H; Scherr DS
Urology; 2009 May; 73(5):1156-62. PubMed ID: 19118885
[TBL] [Abstract][Full Text] [Related]
23. Expression and regulation of non-classical HLA-G in renal cell carcinoma.
Dunker K; Schlaf G; Bukur J; Altermann WW; Handke D; Seliger B
Tissue Antigens; 2008 Aug; 72(2):137-48. PubMed ID: 18721274
[TBL] [Abstract][Full Text] [Related]
24. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas.
Mikami S; Katsube K; Oya M; Ishida M; Kosaka T; Mizuno R; Mochizuki S; Ikeda T; Mukai M; Okada Y
J Pathol; 2009 Aug; 218(4):530-9. PubMed ID: 19455604
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of Id-1 and its association with EGFR in renal cell cancer.
Li X; Zhang Z; Xin D; Chua CW; Wong YC; Leung SC; Na Y; Wang X
Histopathology; 2007 Mar; 50(4):484-90. PubMed ID: 17448024
[TBL] [Abstract][Full Text] [Related]
26. Renal cell carcinoma marker (RCC-Ma) is specific for cutaneous metastasis of renal cell carcinoma.
Perna AG; Ostler DA; Ivan D; Lazar AJ; Diwan AH; Prieto VG; Reed JA
J Cutan Pathol; 2007 May; 34(5):381-5. PubMed ID: 17448192
[TBL] [Abstract][Full Text] [Related]
27. Gene expression profiles correlate with the morphology and metastasis characteristics of renal cell carcinoma cells.
Ami Y; Shimazui T; Akaza H; Uematsu N; Yano Y; Tsujimoto G; Uchida K
Oncol Rep; 2005 Jan; 13(1):75-80. PubMed ID: 15583805
[TBL] [Abstract][Full Text] [Related]
28. Photosensitizing and radiosensitizing effects of hypericin on human renal carcinoma cells in vitro.
Wessels JT; Busse AC; Rave-Fränk M; Zänker S; Hermann R; Grabbe E; Müller GA
Photochem Photobiol; 2008; 84(1):228-35. PubMed ID: 18173725
[TBL] [Abstract][Full Text] [Related]
29. The lymphatic system and its specific growth factor vascular endothelial growth factor C in kidney tissue and in renal cell carcinoma.
Voss M; Steidler A; Grobholz R; Weiss C; Alken P; Michel MS; Trojan L
BJU Int; 2009 Jul; 104(1):94-9. PubMed ID: 19500329
[TBL] [Abstract][Full Text] [Related]
30. Differential profiling analysis of proteins involved in anti-proliferative effect of interferon-alpha on renal cell carcinoma cell lines by protein biochip technology.
Nakamura K; Yoshikawa K; Yamada Y; Saga S; Aoki S; Taki T; Tobiume M; Shimazui T; Akaza H; Honda N
Int J Oncol; 2006 Apr; 28(4):965-70. PubMed ID: 16525647
[TBL] [Abstract][Full Text] [Related]
31. Functional significance of Wnt inhibitory factor-1 gene in kidney cancer.
Kawakami K; Hirata H; Yamamura S; Kikuno N; Saini S; Majid S; Tanaka Y; Kawamoto K; Enokida H; Nakagawa M; Dahiya R
Cancer Res; 2009 Nov; 69(22):8603-10. PubMed ID: 19887605
[TBL] [Abstract][Full Text] [Related]
32. [Expression of S100 protein in renal cell carcinoma and its relation with P53].
Yang JF; Zhang XY; Qi F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):301-4. PubMed ID: 16136965
[TBL] [Abstract][Full Text] [Related]
33. Ex vivo HR-MAS magnetic resonance spectroscopy of normal and malignant human renal tissues.
Righi V; Mucci A; Schenetti L; Tosi MR; Grigioni WF; Corti B; Bertaccini A; Franceschelli A; Sanguedolce F; Schiavina R; Martorana G; Tugnoli V
Anticancer Res; 2007; 27(5A):3195-204. PubMed ID: 17970061
[TBL] [Abstract][Full Text] [Related]
34. C-jun activation in acquired cystic kidney disease and renal cell carcinoma.
Oya M; Mikami S; Mizuno R; Marumo K; Mukai M; Murai M
J Urol; 2005 Aug; 174(2):726. PubMed ID: 16006965
[TBL] [Abstract][Full Text] [Related]
35. Patient samples of renal cell carcinoma show reduced expression of TRAF1 compared with normal kidney and functional studies in vitro indicate TRAF1 promotes apoptosis: potential for targeted therapy.
Rajandram R; Bennett NC; Wang Z; Perry-Keene J; Vesey DA; Johnson DW; Gobe GC
Pathology; 2012 Aug; 44(5):453-9. PubMed ID: 22810054
[TBL] [Abstract][Full Text] [Related]
36. Cathepsin D expression in renal cell cancer-clinical implications.
Merseburger AS; Hennenlotter J; Simon P; Ohneseit PA; Kuehs U; Kruck S; Koch E; Vogel U; Stenzl A; Kuczyk MA
Eur Urol; 2005 Sep; 48(3):519-26. PubMed ID: 16115525
[TBL] [Abstract][Full Text] [Related]
37. Expression of neural cell adhesion molecule in renal cell carcinoma.
Cirović SL; Cegar BS; Vjestica JM; Dundjerović DM; Stojanović MM; Vuksanović AM; Mitrović DB; Lazić MD; Tulić CD; Marković-Lipkovski JZ
Acta Chir Iugosl; 2012; 59(1):39-44. PubMed ID: 22924301
[TBL] [Abstract][Full Text] [Related]
38. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells.
Tang SW; Chang WH; Su YC; Chen YC; Lai YH; Wu PT; Hsu CI; Lin WC; Lai MK; Lin JY
Cancer Lett; 2009 Jan; 273(1):35-43. PubMed ID: 18809243
[TBL] [Abstract][Full Text] [Related]
39. GM2 expression in renal cell carcinoma: potential role in tumor-induced T-cell dysfunction.
Biswas K; Richmond A; Rayman P; Biswas S; Thornton M; Sa G; Das T; Zhang R; Chahlavi A; Tannenbaum CS; Novick A; Bukowski R; Finke JH
Cancer Res; 2006 Jul; 66(13):6816-25. PubMed ID: 16818659
[TBL] [Abstract][Full Text] [Related]
40. Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response.
Balamurugan K; Luu VD; Kaufmann MR; Hofmann VS; Boysen G; Barth S; Bordoli MR; Stiehl DP; Moch H; Schraml P; Wenger RH; Camenisch G
Oncogene; 2009 Sep; 28(37):3274-85. PubMed ID: 19581925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
